Award

Delivery Order #SPE2D326F6830

Delivery Order for Pharmaceutical Syringe Under Long-Term Supply Contract

Buyer

Defense Logistics Agency

Award Amount

$38.52

Ceiling

$38.52

Awarded

March 02, 2026

Period of Performance

Mar 02, 2026 – Mar 03, 2026

Identifier

SPE2D326F6830

NAICS

325411

This award represents a delivery order contract awarded to Sagent Pharmaceuticals, Inc., a prominent manufacturer and distributor specializing in generic pharmaceuticals. The order procures a specific pharmaceutical product—glycopyrrolate 2% jelly in an 11ml syringe—to support ongoing medical needs. This transaction is part of a larger, previously awarded long-term indefinite delivery vehicle (IDV) contract focused on the reliable manufacture and supply of critical medications for military and public health applications. The significance of this contract lies in its role in ensuring timely availability of essential pharmaceutical products, thereby reinforcing healthcare readiness and operational effectiveness. The scope includes the precise fulfillment and delivery of the specified pharmaceutical syringe within a short performance window. This award was made under the existing competitively awarded contract, demonstrating adherence to rigorous procurement standards. The contract's timeline is brief, covering a multi-day period for delivery, indicative of efficient supply chain operations. The delivery order supplements the agency's sustained commitment to pharmaceutical resilience facilitated by Sagent Pharmaceuticals' proven performance.

Description

4571002349!GLYDO 2% JELLY SYRINGE 11ML

View original record